The promise of adoptive cellular immunotherapies in hepatocellular carcinoma

The promise of adoptive cellular immunotherapies in hepatocellular carcinoma

Hepatocellular Carcinoma (HCC) is one of the leading causes of cancer-related mortality worldwide. Current systemic therapies result only in modest benefits and new therapeutic options are critically needed. Some patients show promising clinical responses to immune checkpoint inhibitors, however, ad...

Full description

Bibliographic Details
Main Authors: Peter G. Hendrickson, Michael Olson, Tim Luetkens, Siani Weston, Tiffany Han, Djordje Atanackovic, Gabriel C. Fine
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:OncoImmunology
Subjects:
hepatocellular carcinoma
immunotherapy
adoptive cell transfer
t cells
tumor immunology
car t cells
tcr
Online Access:http://dx.doi.org/10.1080/2162402X.2019.1673129

Internet

http://dx.doi.org/10.1080/2162402X.2019.1673129

Similar Items